Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
Quantum-Si incorporated (QSIAW)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: QSIAW (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -79.71% | Avg. Invested days 25 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.44B USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 27151 | Beta 2.79 | 52 Weeks Range 0.05 - 2.23 | Updated Date 03/29/2025 |
52 Weeks Range 0.05 - 2.23 | Updated Date 03/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -2584.56% |
Management Effectiveness
Return on Assets (TTM) -24.85% | Return on Equity (TTM) -41.48% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 146920085 |
Shares Outstanding - | Shares Floating 146920085 | ||
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Quantum-Si incorporated
Company Overview
History and Background
Quantum-Si incorporated was founded in 2013 with the goal of revolutionizing protein sequencing. The company has focused on developing a next-generation platform to analyze proteins with semiconductor chips.
Core Business Areas
- Next-Generation Protein Sequencing: Developing and commercializing a platform based on semiconductor technology to enable protein sequencing. This is their core offering, aimed at replacing current slow and expensive protein analysis methods.
Leadership and Structure
Dr. Jonathan Rothberg, the founder, is a key figure. The leadership team also includes experienced individuals in engineering, life sciences, and business. The organizational structure focuses on research and development, manufacturing, and commercialization.
Top Products and Market Share
Key Offerings
- Platinumu2122: A semiconductor-based single-molecule protein sequencing platform. Revenue data not publicly available yet. Competitors include traditional protein sequencing technologies, antibody-based assays, mass spectrometry and companies like Illumina (ILMN) in genomics, which could expand into proteomics.
Market Dynamics
Industry Overview
The proteomics market is growing, driven by the increasing importance of proteins in drug discovery, diagnostics, and personalized medicine. Next generation protein sequencing has the opportunity to disrupt current antibody based methods.
Positioning
Quantum-Si aims to be a leader in next-generation protein sequencing by utilizing its semiconductor-based technology, offering faster, more accurate, and more cost-effective protein analysis.
Total Addressable Market (TAM)
The proteomics market size is expected to reach billions of dollars. Quantum-Si is positioned to capture a share of this market by offering its platform.
Upturn SWOT Analysis
Strengths
- Novel semiconductor-based technology
- Experienced leadership team
- Potential for high throughput and low cost
- Strong patent portfolio
Weaknesses
- Limited commercial track record
- High cash burn rate
- Need for significant market adoption
- Dependence on a single product
Opportunities
- Growing proteomics market
- Partnerships with pharmaceutical companies
- Expansion into new applications (diagnostics, drug discovery)
- Potential for cost reduction
Threats
- Competition from established technologies
- Regulatory hurdles
- Technological advancements by competitors
- Market acceptance of new technology
Competitors and Market Share
Key Competitors
- ILMN
- TMO
- DANO
- PACB
Competitive Landscape
Quantum-Si's semiconductor-based approach distinguishes it from competitors. However, established companies have larger market share and more resources.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Historical growth is limited due to the recent commercial launch of their products.
Future Projections: Future growth depends on market adoption of the Platinumu2122 platform and successful partnerships. Analyst estimates vary widely.
Recent Initiatives: Recent initiatives include expanding manufacturing capacity, establishing strategic partnerships, and increasing sales and marketing efforts.
Summary
Quantum-Si is an early-stage company with a disruptive technology. They have significant potential in the growing proteomics market but face challenges from established competitors. Their success hinges on successful commercialization and partnerships. Watch out for negative cash flow and possible cash issues.
Similar Companies
- ILMN
- PACB
- ONT
- NVDA
Sources and Disclaimers
Data Sources:
- Quantum-Si SEC Filings
- Analyst Reports
- Company Website
- Third-party Industry Analysis
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market share data is approximate and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Quantum-Si incorporated
Exchange NASDAQ | Headquaters Branford, CT, United States | ||
IPO Launch date 2021-06-11 | President, CEO & Director Mr. Jeffrey Alan Hawkins | ||
Sector Healthcare | Industry Medical Devices | Full time employees 149 | Website https://www.quantum-si.com |
Full time employees 149 | Website https://www.quantum-si.com | ||
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an available pro mode; Library preparation kits to prepare protein sample for sequencing; Barcoding Kits to optimize the workflow and performance of technology; and Sequencing Kits contains the reagents and consumables used to perform NGPS on the Platinum or Platinum Pro instrument. It also provides Platinum Analysis Software, a cloud-based solution that automates data analysis workflows and provides a user-friendly interface and visualization of the sequencing results. Its products are used in antibody characterization, biomarker identification, protein identification, protein variants, protein barcoding, and post translational modification analysis applications. Quantum-Si incorporated was founded in 2013 is headquartered in Branford, Connecticut.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.